BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 17666363)

  • 1. Polymorphisms of CYP2C19 gene are associated with the efficacy of thalidomide based regimens in multiple myeloma.
    Li Y; Hou J; Jiang H; Wang D; Fu W; Yuan Z; Chen Y; Zhou L
    Haematologica; 2007 Sep; 92(9):1246-9. PubMed ID: 17666363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of CYP2C19 gene polymorphism on efficacy of thalidomide-based regimens for the treatment of multiple myeloma].
    Li YH; Hou J
    Zhonghua Xue Ye Xue Za Zhi; 2007 Oct; 28(10):651-4. PubMed ID: 18399167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetic associations of CYP2C19 genotype with in vivo metabolisms and pharmacological effects of thalidomide.
    Ando Y; Price DK; Dahut WL; Cox MC; Reed E; Figg WD
    Cancer Biol Ther; 2002; 1(6):669-73. PubMed ID: 12642692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No influence of the polymorphisms CYP2C19 and CYP2D6 on the efficacy of cyclophosphamide, thalidomide, and bortezomib in patients with Multiple Myeloma.
    Vangsted AJ; Søeby K; Klausen TW; Abildgaard N; Andersen NF; Gimsing P; Gregersen H; Vogel U; Werge T; Rasmussen HB
    BMC Cancer; 2010 Aug; 10():404. PubMed ID: 20684753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of CYP2C19 and MDR1 polymorphisms on cure rate in patients with acid-related disorders with Helicobacter pylori infection.
    Gawrońska-Szklarz B; Wrześniewska J; Starzyńska T; Pawlik A; Safranow K; Ferenc K; Droździk M
    Eur J Clin Pharmacol; 2005 Jul; 61(5-6):375-9. PubMed ID: 15976989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of low-dose thalidomide and dexamethasone as first salvage regimen in multiple myeloma.
    Palumbo A; Bertola A; Falco P; Rosato R; Cavallo F; Giaccone L; Bringhen S; Musto P; Pregno P; Caravita T; Ciccone G; Boccadoro M
    Hematol J; 2004; 5(4):318-24. PubMed ID: 15297848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-1beta genetic polymorphism influences the effect of cytochrome P 2C19 genotype on the cure rate of 1-week triple therapy for Helicobacter pylori infection.
    Take S; Mizuno M; Ishiki K; Nagahara Y; Yoshida T; Inaba T; Yamamoto K; Okada H; Yokota K; Oguma K; Shiratori Y
    Am J Gastroenterol; 2003 Nov; 98(11):2403-8. PubMed ID: 14638340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of cytochrome P450 2C19 gene variations on pharmacokinetic parameters of thalidomide in Japanese patients.
    Matsuzawa N; Nakamura K; Matsuda M; Ishida F; Ohmori S
    Biol Pharm Bull; 2012; 35(3):317-20. PubMed ID: 22382316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of CYP2C19 genetic polymorphism on treatment efficacy of Helicobacter pylori infection with rabeprazole-based triple therapy in Chinese].
    He XX; Zhao YH; Hao YT
    Zhonghua Nei Ke Za Zhi; 2004 Jan; 43(1):13-5. PubMed ID: 14990013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of triple therapy with rabeprazole for Helicobacter pylori infection in relation to CYP2C19 genotype.
    Lee SB; Park SJ; Ryu JK; Lee JK; Kim HJ; Bae JS; Jung HS; Park SM
    Korean J Gastroenterol; 2003 Dec; 42(6):468-75. PubMed ID: 14695703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concomitant dosing of famotidine with a triple therapy increases the cure rates of Helicobacter pylori infections in patients with the homozygous extensive metabolizer genotype of CYP2C19.
    Okudaira K; Furuta T; Shirai N; Sugimoto M; Miura S
    Aliment Pharmacol Ther; 2005 Feb; 21(4):491-7. PubMed ID: 15710002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic polymorphism of CYP2C9 and CYP2C19 in a Bolivian population: an investigative and comparative study.
    Bravo-Villalta HV; Yamamoto K; Nakamura K; Bayá A; Okada Y; Horiuchi R
    Eur J Clin Pharmacol; 2005 May; 61(3):179-84. PubMed ID: 15776277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of the cytochrome P450 2C19 genetic polymorphism.
    Desta Z; Zhao X; Shin JG; Flockhart DA
    Clin Pharmacokinet; 2002; 41(12):913-58. PubMed ID: 12222994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influences of proinflammatory and anti-inflammatory cytokine polymorphisms on eradication rates of clarithromycin-sensitive strains of Helicobacter pylori by triple therapy.
    Sugimoto M; Furuta T; Shirai N; Ikuma M; Hishida A; Ishizaki T
    Clin Pharmacol Ther; 2006 Jul; 80(1):41-50. PubMed ID: 16815316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poor metabolizer genotype status of CYP2C19 is a risk factor for developing gastric cancer in Japanese patients with Helicobacter pylori infection.
    Sugimoto M; Furuta T; Shirai N; Nakamura A; Kajimura M; Sugimura H; Hishida A; Ishizaki T
    Aliment Pharmacol Ther; 2005 Nov; 22(10):1033-40. PubMed ID: 16268979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term results of thalidomide and dexamethasone (thal-dex) as therapy of first relapse in multiple myeloma.
    Zamagni E; Petrucci A; Tosi P; Tacchetti P; Perrone G; Brioli A; Pantani L; Zannetti B; Terragna C; Baccarani M; Cavo M
    Ann Hematol; 2012 Mar; 91(3):419-26. PubMed ID: 21901342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical role of cytochrome p450 genotypes in Helicobacter pylori management.
    Sapone A; Vaira D; Trespidi S; Perna F; Gatta L; Tampieri A; Ricci C; Cantelli-Forti G; Miglioli M; Biagi GL; Paolini M
    Am J Gastroenterol; 2003 May; 98(5):1010-5. PubMed ID: 12809821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CYP2C9 and CYP2C19 genetic polymorphisms: frequencies in the south Indian population.
    Jose R; Chandrasekaran A; Sam SS; Gerard N; Chanolean S; Abraham BK; Satyanarayanamoorthy K; Peter A; Rajagopal K
    Fundam Clin Pharmacol; 2005 Feb; 19(1):101-5. PubMed ID: 15660966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytochrome P450 2C19 loss-of-function polymorphism is associated with an increased treatment-related mortality in patients undergoing allogeneic transplantation.
    Elmaagacli AH; Koldehoff M; Steckel NK; Trenschel R; Ottinger H; Beelen DW
    Bone Marrow Transplant; 2007 Oct; 40(7):659-64. PubMed ID: 17680025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYP2C19 polymorphism affects personality traits of Japanese females.
    Ishii G; Suzuki A; Oshino S; Shiraishi H; Otani K
    Neurosci Lett; 2007 Jan; 411(1):77-80. PubMed ID: 17052843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.